NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹189 Cr | ₹122 Cr | ₹147 Cr | ₹180 Cr | ₹170 Cr |
What is the latest Total Non-Current Liabilities ratio of NEULAND LABORATORIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹189 Cr |
Mar2024 | ₹122 Cr |
Mar2023 | ₹147 Cr |
Mar2022 | ₹180 Cr |
Mar2021 | ₹170 Cr |
How is Total Non-Current Liabilities of NEULAND LABORATORIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹189 Cr | 55.02 | |
Mar2024 | ₹122 Cr | -16.73 | |
Mar2023 | ₹147 Cr | -18.42 | |
Mar2022 | ₹180 Cr | 5.90 | |
Mar2021 | ₹170 Cr | - |
Compare Total Non-Current Liabilities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹16,986.2 Cr | -3.4% | 10.7% | 53.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,219.0 Cr | 0.4% | 1.7% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,227.0 Cr | -0.3% | -3.8% | 35.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,643.0 Cr | 3.9% | 11.8% | 20% | Stock Analytics | |
CIPLA | ₹125,541.0 Cr | 1.5% | 3.8% | 2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,063.0 Cr | -0.5% | -0.1% | -5.1% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -3.4% |
10.7% |
53.7% |
SENSEX | -1.2% |
-3% |
-0.2% |
You may also like the below Video Courses